Sign Up for a Free Account
  • Updated 04.21.2020
  • Released 03.27.2001
  • Expires For CME 04.21.2023

Hypothalamic hamartoma with gelastic seizures



In this article, the author provides a review of hypothalamic hamartoma, with an emphasis on treatment options. Hypothalamic hamartoma is a rare malformation in the ventral hypothalamus, resulting in treatment-resistant (drug-resistant) epilepsy, including gelastic seizures. However, multiple surgical approaches are now available. Treatment should be individualized to the patient’s clinical course and the surgical anatomy of the hypothalamic hamartoma. MR-guided laser interstitial thermal therapy including near real-time MR thermography is the most recently developed surgical treatment option for this disease. Reports describe relatively favorable outcomes for safety and efficacy. Minimally invasive stereotactic techniques (with either laser interstitial thermal therapy or radiofrequency thermoablation) are gaining favor as treatment of first choice for most hypothalamic hamartoma patients.

Key points

• Hypothalamic hamartoma should be considered in any patient with gelastic seizures and in any child with early onset of precocious puberty.

• Seizures associated with hypothalamic hamartoma are rarely controlled with antiepilepsy drugs.

• Cognitive impairment and psychiatric symptoms are common comorbid features with hypothalamic hamartoma and epilepsy.

• Surgical treatment of the hypothalamic hamartoma can control seizures and stabilize (or even improve) cognitive and psychiatric symptoms.

• The best surgical approach is chosen after considering each patient’s clinical course and surgical anatomy.

Historical note and terminology

The first description of hypothalamic hamartoma as a cause of precocious puberty (and probably gelastic seizures, although the symptoms were not recognized as such) was published in 1934 (52). In 1958, List and colleagues recognized the association between hypothalamic hamartoma and gelastic seizures (54). In 1988, Berkovic and colleagues described 4 children with hypothalamic hamartoma, treatment-resistant epilepsy, and progressive neurobehavioral deficits, providing the first definitive description of the catastrophic epilepsy syndrome that we recognize today (04).

Hypothalamic hamartoma can cause 2 distinct clinical syndromes (36; 29). Central precocious puberty is associated with hypothalamic hamartoma lesions that attach anteriorly to the ventral hypothalamus, near the tuber cinereum and pituitary stalk. These have been classified as “parahypothalamic” or “pedunculated” based on the local anatomy.

The second syndrome consists of the neurologic symptoms, usually beginning with gelastic (laughing) seizures, but often progressing to additional, more disabling seizure types, along with cognitive impairment and behavioral symptoms. These hypothalamic hamartoma lesions attach posteriorly in the ventral hypothalamus, in the region of the mammillary bodies, and have been referred to as “intrahypothalamic” or “sessile”. Approximately 40% of hypothalamic hamartoma patients with epilepsy also have central precocious puberty, due to larger lesions that have both an anterior and posterior plane of attachment to the hypothalamus.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125